Five notes:
1. Worldwide revenue was $40.3 million in the third quarter, a 19% increase year over year.
2. U.S. revenue was $38.3 million, an 18% increase year over year.
3. The company saw a net loss of $6.6 million.
4. There are more than 1,200 physicians in the U.S. using SI-Bone’s products in the third quarter, a 15% increase year over year.
5. SI-Bone also refinanced a $36 million term loan, lowered all-in borrowing costs and extended maturity to 2029.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
